1 Program with head enzyme
Haemorrhoids may be used in the Hp eradication treatment for penicillin allergies. The reasons are as follows:
Head bacterium and Amosicillin are the same β-neamide drugs, with a high bioavailability of oral bacterium estuarine in line with antibacterial mechanisms; low Hp resistance to head bacterium; no more than 2 per cent resistance from generation to generation; and a few studies have suggested that eradication programmes containing head bacterium can achieve better therapeutic results.
An Italian study compares the three-pronged programme, which includes Amosicillin or a chrysanthemum, and two programmes have relatively different eradication rates that have no statistical significance.
The safety of penicillin allergies is also a clinical concern. In fact, no more than 10 per cent of penicillin and capecin have cross-sensitivity, and even studies have found no increase in the proportion of penicillin-sensitive populations. The cross-sensitivity of penicillin and headgillin originates from similar side-link structures, so that cross-sensitivity with penicillin or amoxicillin is mainly found in one generation of cyllin, with second or third generations having little cross-sensitivity to penicillin. Thus, penicillin allergies are safe for the use of headgills, especially second- or third-generation sepsis. More clinical research is needed to confirm the efficacy of the use of thorogen for penicillin allergies.
2. Minocrine-containing programmes
As a semi-synthetic tetracycline, which is safer and has a longer half-life, Hp is less than 7 per cent resistant to the menocycline, and thus is likely to be used as an alternative to tetracycline to eradicate the Hp, especially for those who are allergic to penicillin.
A study in Japan compared the Triple Programme containing Cracicillin or Minocrin, with a eradication rate of only 38.5 per cent for the Triple Programme containing Minocrin, significantly lower than the Triple Programme containing Carcinogen (82.5 per cent); however, in the case of bacterial strains that are sensitive to Metrazine, the Triple Programme for PPI+Minocycline+Metrazine + Metrazine could reach 85 per cent for remediation treatment. More research is needed to test the efficacy of the Minocyclic eradication of Hp.
3. Programmes containing new quinone
The programme for the eradication of Hp, which contains new quinone, such as a salsa star, has had better effects.
A study in Lebanon showed a eradication rate of 83 per cent for the Triple Programme (Rebeiraaz+Texas+Amosilin) and 92 per cent at 40 mg/d of Rebellaazole. A study in Hubei showed a eradication rate of 92.5 per cent – 95 per cent for the Triple Programme (14d PPI+Add Saser+Amosilin or Metrazine), which is significantly higher than for the non-Salsat programme. However, our Hp’s resistance to left-oxen salsa is increasing year by year, while quinone-type drugs are subject to cross-resistant drug resistance, and studies of other bacteria, such as pneumocococcus, show that the strain of left-oxen salsa resistance is entirely resistant to the cyclopropsa and is not sensitive to any of the extra salsa. In addition, the adverse effects on sugar metabolism caused by the addition of sand stars are gradually gaining attention, and the safety and effectiveness of the programme with the addition of sand stars require more research to clarify.
4. Programs containing Lifoping or Lifbutin
Lifoping or Lifbutin are currently used for third or fourth-line treatment, both in the country and abroad.
A study in Korea showed that the Triple Programme, which contains Lifobutin, used Hp Remedial Treatment to analyse the PPP eradication rate of 80.6 per cent, with a 100 per cent eradication rate of Lantsola added to 120 mg/d. However, our country is a large country of nodules, and many patients have been treated with lefopards, which has resulted in a high rate of lifopine tolerance, and our Hp has over 10 per cent resistance to Lifoppin.
A study in Zhejiang showed that the Triad programme, including Li Fokping, was used for the initial Hp eradication rate of 87 per cent, with no statistical differences compared to Standard Triad. In the context of drug resistance in our country, the efficacy of first-line treatment for penicillin allergies, with Lifoping or Lifbutin, remains to be studied further.
